Sangamo Biosciences (SGMO) Files $100M Mixed Shelf
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Join SI Premium – FREE
Sangamo Biosciences, Inc. (Nasdaq: SGMO), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silence Therapeutics closes $201M public offering of ADSs
- L Catterton to sell $1B in Birkenstock shares in secondary offering
- Sangamo picks Lilly and PTC as buyers in bankruptcy auction
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
